RxDoctor Payments Data

Rachel Huckfeldt, MD

Ophthalmology · Stoneham, MANPI 1205160173

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $32,520 of the $38,941 with a category attached, or 83.5%. Johnson & Johnson accounts for 64.6% of it on its own, with 8 other manufacturers making up the rest. Among ophthalmology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,941in general payments, 2019–2025

Across 56 payments — averaging $695.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$25K
  • Sanofi US Services Inc.$5K
  • Regeneron$4K
  • Sumitomo Pharma America, Inc.$4K
  • Spark Therapeutics, Inc.$298
  • Janssen Global Services, LLC$114
  • plus $45 from 3 others
$1,693,140in research payments, 2019–2025

Across 77 payments — averaging $21,989 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$1.4M
  • Biogen$223K
  • Spark Therapeutics, Inc.$75K
  • Novartis$3K
  • AbbVie$11

What the payments were for

  • Consulting fees$32,52084%
  • Travel & lodging$5,22113%
  • Food & beverage$1,1803%
  • Education$210%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,941 in reported general payments places this provider in the 90th percentile of 653 ophthalmology providers in Massachusetts.

See all ophthalmology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$14,484
Medicare patients
89
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Stoneham

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →